Compugen
CGEN
#8640
Rank
HK$1.84 B
Marketcap
HK$19.52
Share price
6.41%
Change (1 day)
64.67%
Change (1 year)

Earnings for Compugen (CGEN)

Earnings in 2026 (TTM): HK$0.27 Billion

According to Compugen's latest financial reports the company's current earnings are HK$72.65 Million. In 2025 the company made an earning of HK$0.27 Billion, an increase over its 2024 earnings that were of -HK$76.11 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Compugen from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) HK$0.27 B-2.53%
2025 HK$0.27 B-464.58%
2024 -HK$76.11 Million-0.77%
2023 -HK$76.7 Million-70.91%
2022 -HK$0.27 Billion-1.66%
2021 -HK$0.27 Billion15.17%
2020 -HK$0.24 Billion5.84%
2019 -HK$0.22 Billion24.16%
2018 -HK$0.18 Billion-39.03%
2017 -HK$0.3 Billion17.72%
2016 -HK$0.25 Billion59.22%
2015 -HK$0.16 Billion84.23%
2014 -HK$84.15 Million-20.97%
2013 -HK$0.11 Billion-5.86%
2012 -HK$0.12 Billion20.44%
2011 -HK$93.91 Million52.06%
2010 -HK$61.76 Million3.26%
2009 -HK$59.81 Million-37.67%
2008 -HK$95.94 Million-3.37%
2007 -HK$99.29 Million-8.64%
2006 -HK$0.11 Billion
2004 -HK$0.13 Billion9.57%
2003 -HK$0.12 Billion-5.5%
2002 -HK$0.12 Billion-20.9%
2001 -HK$0.15 Billion27.35%
2000 -HK$0.12 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Seagen
SGEN
-HK$6.2 Billion-2,366.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
-HK$30.3 Million-111.08%๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
HK$17.80 B 6,410.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Eterna Therapeutics
ERNA
-HK$0.12 Billion-142.76%๐Ÿ‡บ๐Ÿ‡ธ USA